BioArctic AB (publ) (STO:BIOA.B)
Sweden
· Delayed Price · Currency is SEK 299.00
+0.20 (0.07%)
Mar 9, 2026, 4:31 PM CET
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,999 | 257.35 | 616 | 228.29 | 23.15 | Upgrade
|
| Other Revenue | - | - | - | 1.14 | 2.52 | Upgrade
|
| Revenue | 1,999 | 257.35 | 616 | 229.43 | 25.66 | Upgrade
|
| Revenue Growth (YoY) | 676.80% | -58.22% | 168.49% | 794.02% | -60.64% | Upgrade
|
| Cost of Revenue | 59.22 | 26.98 | 14.99 | 74.33 | 55.07 | Upgrade
|
| Gross Profit | 1,940 | 230.37 | 601.01 | 155.11 | -29.4 | Upgrade
|
| Selling, General & Admin | 194.83 | 148.84 | 172.18 | 148.67 | 97.35 | Upgrade
|
| Research & Development | 376.92 | 311.15 | 172.14 | - | - | Upgrade
|
| Other Operating Expenses | -16.2 | - | -0.27 | -0.25 | -0.01 | Upgrade
|
| Operating Expenses | 555.55 | 459.99 | 344.05 | 163.04 | 110.45 | Upgrade
|
| Operating Income | 1,384 | -229.62 | 256.96 | -7.94 | -139.85 | Upgrade
|
| Interest Expense | -37.9 | - | -0.33 | -0.56 | -0.84 | Upgrade
|
| Interest & Investment Income | 34.68 | 40.85 | 34.23 | 2.54 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -125.54 | -0.75 | -14.32 | -5.01 | 0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | -0.05 | -0.19 | -0.15 | Upgrade
|
| EBT Excluding Unusual Items | 1,256 | -189.52 | 276.49 | -11.17 | -140.5 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | Upgrade
|
| Pretax Income | 1,256 | -189.52 | 276.49 | -11.17 | -140.51 | Upgrade
|
| Income Tax Expense | 233.26 | -12.44 | 47.24 | 0.01 | -20.72 | Upgrade
|
| Net Income | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 | Upgrade
|
| Net Income to Common | 1,022 | -177.08 | 229.25 | -11.18 | -119.79 | Upgrade
|
| Shares Outstanding (Basic) | 89 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 89 | 88 | 89 | 88 | Upgrade
|
| Shares Change (YoY) | 0.25% | 0.04% | -0.22% | 0.71% | - | Upgrade
|
| EPS (Basic) | 11.55 | -2.00 | 2.60 | -0.13 | -1.36 | Upgrade
|
| EPS (Diluted) | 11.52 | -2.00 | 2.59 | -0.13 | -1.36 | Upgrade
|
| Free Cash Flow | 1,431 | -342.97 | 302.25 | -44.38 | -144.84 | Upgrade
|
| Free Cash Flow Per Share | 16.13 | -3.87 | 3.42 | -0.50 | -1.65 | Upgrade
|
| Dividend Per Share | 2.000 | - | - | - | - | Upgrade
|
| Gross Margin | 97.04% | 89.52% | 97.57% | 67.60% | -114.58% | Upgrade
|
| Operating Margin | 69.25% | -89.22% | 41.71% | -3.46% | -544.96% | Upgrade
|
| Profit Margin | 51.14% | -68.81% | 37.22% | -4.87% | -466.78% | Upgrade
|
| Free Cash Flow Margin | 71.58% | -133.27% | 49.07% | -19.35% | -564.40% | Upgrade
|
| EBITDA | - | -211.19 | 275.39 | -1.87 | -134.72 | Upgrade
|
| EBITDA Margin | - | -82.06% | 44.71% | -0.82% | - | Upgrade
|
| D&A For EBITDA | - | 18.43 | 18.43 | 6.07 | 5.13 | Upgrade
|
| EBIT | 1,384 | -229.62 | 256.96 | -7.94 | -139.85 | Upgrade
|
| EBIT Margin | 69.25% | -89.22% | 41.71% | -3.46% | - | Upgrade
|
| Effective Tax Rate | 18.58% | - | 17.09% | - | - | Upgrade
|
| Revenue as Reported | - | - | - | -228.63 | 26.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.